Cantor Fitzgerald Boosts MKS (NASDAQ:MKSI) Price Target to $300.00

MKS (NASDAQ:MKSI) had its target price raised by stock analysts at Cantor Fitzgerald from $200.00 to $300.00 in a report released on Tuesday, MarketBeat reports. The brokerage currently has an “overweight” rating on the scientific and technical instruments company’s stock. Cantor Fitzgerald’s price objective indicates a potential upside of 35.91% from the company’s previous close.

MKSI has been the topic of a number of other research reports. KeyCorp upped their target price on MKS from $180.00 to $250.00 and gave the stock an “overweight” rating in a research note on Friday, January 16th. Morgan Stanley restated an “overweight” rating and issued a $151.00 price objective on shares of MKS in a research report on Monday, October 13th. Wall Street Zen cut shares of MKS from a “strong-buy” rating to a “buy” rating in a research note on Saturday, January 3rd. The Goldman Sachs Group boosted their target price on shares of MKS from $92.00 to $125.00 and gave the company a “sell” rating in a research note on Thursday, October 9th. Finally, Benchmark raised their price target on shares of MKS from $135.00 to $180.00 and gave the company a “buy” rating in a research report on Friday, November 7th. Nine equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, MKS currently has an average rating of “Moderate Buy” and an average price target of $198.27.

MKS Stock Up 4.8%

MKSI stock opened at $220.73 on Tuesday. The company has a market capitalization of $14.83 billion, a P/E ratio of 53.58, a price-to-earnings-growth ratio of 1.94 and a beta of 1.92. MKS has a 12 month low of $54.84 and a 12 month high of $221.07. The firm’s fifty day simple moving average is $166.29 and its 200-day simple moving average is $134.80. The company has a debt-to-equity ratio of 1.64, a current ratio of 2.86 and a quick ratio of 1.81.

MKS (NASDAQ:MKSI) last issued its earnings results on Wednesday, November 5th. The scientific and technical instruments company reported $1.93 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.80 by $0.13. MKS had a net margin of 7.25% and a return on equity of 20.80%. The firm had revenue of $988.00 million during the quarter, compared to analysts’ expectations of $963.87 million. During the same quarter last year, the company posted $1.72 earnings per share. The firm’s revenue was up 10.3% compared to the same quarter last year. MKS has set its Q4 2025 guidance at 1.930-2.610 EPS. As a group, equities research analysts forecast that MKS will post 6.94 earnings per share for the current year.

Insider Activity

In other news, Director Elizabeth Mora sold 300 shares of the business’s stock in a transaction dated Tuesday, December 2nd. The shares were sold at an average price of $158.81, for a total transaction of $47,643.00. Following the completion of the sale, the director owned 18,963 shares of the company’s stock, valued at $3,011,514.03. The trade was a 1.56% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.57% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On MKS

Institutional investors have recently bought and sold shares of the company. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in shares of MKS by 3.6% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 267,421 shares of the scientific and technical instruments company’s stock valued at $21,434,000 after acquiring an additional 9,170 shares during the last quarter. Parallel Advisors LLC increased its position in shares of MKS by 63.9% during the second quarter. Parallel Advisors LLC now owns 952 shares of the scientific and technical instruments company’s stock worth $95,000 after purchasing an additional 371 shares in the last quarter. Assenagon Asset Management S.A. purchased a new stake in shares of MKS during the second quarter worth approximately $991,000. UMB Bank n.a. raised its stake in MKS by 55.8% in the 2nd quarter. UMB Bank n.a. now owns 975 shares of the scientific and technical instruments company’s stock valued at $97,000 after purchasing an additional 349 shares during the last quarter. Finally, GAMMA Investing LLC lifted its holdings in MKS by 112.7% in the 2nd quarter. GAMMA Investing LLC now owns 2,529 shares of the scientific and technical instruments company’s stock valued at $251,000 after purchasing an additional 1,340 shares in the last quarter. 99.79% of the stock is currently owned by institutional investors and hedge funds.

About MKS

MKS Instruments, Inc (NASDAQ: MKSI) designs, manufactures and markets technology solutions that enable advanced processes in a variety of high‐technology and industrial markets. The company’s core offerings include vacuum and gas delivery systems, pressure and flow measurement instruments, optical metrology tools, photonics subsystems and critical components for manufacturing processes. These products support the precise control and monitoring needs of semiconductor, industrial manufacturing, life and health sciences, and research applications.

The company’s product portfolio features mass flow controllers, pressure transducers, vacuum gauges, gas purity monitors, laser-based metrology systems and photonic devices such as lasers and detectors.